![]() |
|
|
Department of Biochemistry, Institute for Cancer Research, Osaka University Medical School, 1-1-50, Fukushima, Fukushima-ku, Osaka 553, Japan
The availability of cysteine moiety released from dietary glutathione (GSH) for protein synthesis in rats was studied to determine the L-methionine-sparing effect of this peptide. Animals were fed diets containing 18% of an amino acid mixture having a composition similar to that of whole egg, with or without GSH. The proportions of L-methionine, L-cysteine and GSH in the diet were varied, and one of these components was labeled with 35S. The incorporation of label into proteins and GSH in the liver and into proteins in the plasma was determined to assess the utilization of the sulfur atoms in these sulfur-containing substances. Dietary [35S]GSH was found to be incorporated efficiently into proteins and GSH in the liver and into plasma proteins. The results demonstrate the L-methionine-sparing effect of dietary GSH, in terms of incorporation of its 35S into proteins and GSH. GSH spared L-methionine almost as efficiently as L-cysteine in plasma protein synthesis, though slightly less in liver protein synthesis. The effect of GSH increased with increase in its concentration in the diet.
KEY WORDS: methionine-sparing effect methionine cysteine glutathione liver protein plasma protein
1 A part of this work was presented orally at the International Symposium on "Glutathione-Storage, Transport and Turnover in Mammals" held on December 11, 1981 in Osaka, Japan [to be published by Japan Sci. Soc. Press (Sakamoto, Y., Higashi, T. & Tateishi, N., eds.)] and at the 5th Karolinska Institute Nobel Conference "Functions of GlutathioneBiochemical, Physiological and Toxicological Aspects" held on May 2327, 1982 in Skokloster, Sweden [to be published by Raven Press, New York (Larsson, A., Orrenius, S. & Holmgren, A., eds.) in 1983].
2 This work was supported by a Grant-in-Aid for Scientific Research (No. 57580031) from the Ministry of Education, Science and Culture of Japan and in part by the Yamanouchi Pharmaceutical Co., Ltd.
Manuscript received 20 January 1982.